Who owns ASPIRE BIOPHARMA HLDGS INC?
- CUSIP Number: 738920305
Tip: Access positions for across all investors
Analyze quarterly positions in Aspire Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aspire Biopharma Hldgs stock
Who bought or sold ASPIRE BIOPHARMA HLDGS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 15k | $79k | 100% | Jun 2026 |
|
| Geode Capital Management | 11k | $56k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 10k | $56k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 10k | $54k | 100% | Jun 2026 |
|
| Crewe Advisors | 677.00 | $3.6k | 100% | Jun 2026 |
|
| Tower Research Capital | 283.00 | $1.5k | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 166.00 | $885.991800 | 100% | Jun 2026 |
|
| Efficient Wealth Management | 45.00 | $0 | 100% | Jun 2026 |
|
| Crossingbridge Advisors | 20.00 | $107.000000 | 100% | Jun 2026 |
|
| Mercer Global Advisors | 3.00 | $15.999900 | 100% | Jun 2026 |
|
| SBI Securities | 2.00 | $11.000000 | 100% | Jun 2026 |
|
| Barclays | 1.00 | $5.000000 | 100% | Jun 2026 |
|
| UBS Group | 1.00 | $5.000000 | 100% | Jun 2026 |
|